High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$20.0M
$20,029,986
Total Sells (Filtered)
$2.2M
$2,223,357
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
AKTS
P
Aktis Oncology, Inc.
GADICKE ANSBERT
• 10% Owner
Discretionary BuyΔOwn +12.2%
2026-01-12
$20,029,986MEGA
|
||||||
| AKTS |
Aktis Oncology, Inc.
|
10% Owner
Discretionary BuyΔOwn +12.2%
|
2026-01-12 | $20,029,986MEGA | P | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
Other
10b5-1 Sell
|
2025-12-04 | $80,733 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
Other
10b5-1 Sell
|
2025-12-03 | $49,786 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
Other
10b5-1 Sell
|
2025-12-02 | $52,757 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
10% Owner
10b5-1 Sell
|
2025-12-01 | $57,262 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
10% Owner
10b5-1 Sell
|
2025-11-28 | $20,074 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
10% Owner
10b5-1 Sell
|
2025-11-26 | $59,518 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
10% Owner
10b5-1 Sell
|
2025-11-25 | $39,130 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
10% Owner
10b5-1 Sell
|
2025-11-24 | $87,026 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
10% Owner
10b5-1 Sell
|
2025-11-21 | $53,395 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
10% Owner
10b5-1 Sell
|
2025-11-20 | $36,625 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
10% Owner
10b5-1 Sell
|
2025-11-19 | $62,345 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
10% Owner
10b5-1 Sell
|
2025-11-18 | $48,943 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
10% Owner
10b5-1 Sell
|
2025-11-17 | $54,208 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
10% Owner
10b5-1 Sell
|
2025-11-14 | $57,325 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
10% Owner
10b5-1 Sell
|
2025-11-13 | $89,132 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
10% Owner
10b5-1 Sell
|
2025-11-12 | $44,329 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
10% Owner
10b5-1 Sell
|
2025-11-11 | $63,623 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
10% Owner
10b5-1 Sell
|
2025-11-10 | $57,313 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
10% Owner
10b5-1 Sell
|
2025-11-07 | $76,013 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
10% Owner
10b5-1 Sell
|
2025-11-06 | $65,887 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
10% Owner
10b5-1 Sell
|
2025-11-05 | $58,499 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
10% Owner
10b5-1 Sell
|
2025-11-04 | $171,395 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
10% Owner
10b5-1 Sell
|
2025-11-03 | $121,341 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
10% Owner
10b5-1 Sell
|
2025-10-31 | $145,976 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
10% Owner
10b5-1 Sell
|
2025-10-30 | $124,318 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
10% Owner
10b5-1 Sell
|
2025-10-29 | $208,072 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
10% Owner
10b5-1 Sell
|
2025-10-28 | $113,272 | S | Form 4 |
| HOWL |
Werewolf Therapeutics, Inc.
|
10% Owner
10b5-1 Sell
|
2025-10-27 | $125,059 | S | Form 4 |